Geron Corporation (GERN) financial statements (2020 and earlier)

Company profile

Business Address 149 COMMONWEALTH DRIVE
MENLO PARK, CA 94025
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1391639511511415165
Cash and cash equivalents21111613214313
Short-term investments118153781029310952
Restricted cash and investments000000 
Receivables110011 
Prepaid expense 111110
Other undisclosed current assets2     1
Total current assets:1421669611611615367
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Long-term investments and receivables201914143319 
Long-term investments201914143319 
Deposits noncurrent assets      0
Other noncurrent assets11     
Total noncurrent assets:2219141433190
TOTAL ASSETS:16418511013014917367
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10555477
Accounts payable2110011
Accrued liabilities5111122
Employee-related liabilities3333344
Debt0      
Restructuring reserve    0 
Other undisclosed current liabilities13232350
Total current liabilities:128787428
Noncurrent Liabilities
Total liabilities:128787428
Stockholders' equity
Stockholders' equity attributable to parent15217810412214213160
Common stock0000000
Additional paid in capital1,2031,1891,0901,0801,0711,059952
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)(0)(0)
Accumulated deficit(1,051)(1,011)(986)(958)(928)(928)(893)
Total stockholders' equity:15217810412214213160
TOTAL LIABILITIES AND EQUITY:16418511013014917367

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net  35  
Gross profit:011636 1
Operating expenses(53)(32)(30)(37)(37)(37)(40)
Other undisclosed operating income0    1 
Operating loss:(52)(31)(29)(31)(1)(36)(39)
Nonoperating expense
(Other Nonoperating expense)
(0)(0)(0)(0)(0)(0)(0)
Loss before gain (loss) on sale of properties:(52)(31)(29)(31)(1)(36)(39)
Other undisclosed net income44     
Net loss:(49)(27)(29)(31)(1)(36)(39)
Other undisclosed net income attributable to parent2 11111
Net income (loss) available to common stockholders, diluted:(47)(27)(28)(30)0(36)(38)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(49)(27)(29)(31)(1)(36)(39)
Other comprehensive income 0     
Other undisclosed comprehensive income0      
Comprehensive loss:(49)(27)(29)(31)(1)(36)(39)
Other undisclosed comprehensive income, net of tax, attributable to parent2 11111
Comprehensive loss, net of tax, attributable to parent:(46)(27)(28)(29)(0)(36)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: